Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec 4;18(1):83-90.
doi: 10.1038/nm.2540.

Key contribution of CPEB4-mediated translational control to cancer progression

Affiliations

Key contribution of CPEB4-mediated translational control to cancer progression

Elena Ortiz-Zapater et al. Nat Med. .

Abstract

Malignant transformation, invasion and angiogenesis rely on the coordinated reprogramming of gene expression in the cells from which the tumor originated. Although deregulated gene expression has been extensively studied at genomic and epigenetic scales, the contribution of the regulation of mRNA-specific translation to this reprogramming is not well understood. Here we show that cytoplasmic polyadenylation element binding protein 4 (CPEB4), an RNA binding protein that mediates meiotic mRNA cytoplasmic polyadenylation and translation, is overexpressed in pancreatic ductal adenocarcinomas and glioblastomas, where it supports tumor growth, vascularization and invasion. We also show that, in pancreatic tumors, the pro-oncogenic functions of CPEB4 originate in the translational activation of mRNAs that are silenced in normal tissue, including the mRNA of tissue plasminogen activator, a key contributor to pancreatic ductal adenocarcinoma malignancy. Taken together, our results document a key role for post-transcriptional gene regulation in tumor development and describe a detailed mechanism for gene expression reprogramming underlying malignant tumor progression.

PubMed Disclaimer

References

    1. J Clin Oncol. 2009 Apr 10;27(11):1806-13 - PubMed
    1. Trends Biochem Sci. 2007 Jun;32(6):279-85 - PubMed
    1. Cell. 1988 Feb 12;52(3):321-8 - PubMed
    1. Curr Cancer Drug Targets. 2009 Feb;9(1):32-71 - PubMed
    1. Gastroenterology. 2009 Apr;136(4):1379-90, e1-5 - PubMed

Publication types

MeSH terms

LinkOut - more resources